Shnayder, N.A.; Pekarets, N.A.; Pekarets, N.I.; Dmitrenko, D.V.; Grechkina, V.V.; Petrova, M.M.; Al-Zamil, M.; Nasyrova, R.F.
MicroRNAs as Epigenetic Biomarkers of Pathogenetic Mechanisms of the Metabolic Syndrome Induced by Antiseizure Medications: Systematic Review. J. Clin. Med. 2025, 14, 2432.
https://doi.org/10.3390/jcm14072432
AMA Style
Shnayder NA, Pekarets NA, Pekarets NI, Dmitrenko DV, Grechkina VV, Petrova MM, Al-Zamil M, Nasyrova RF.
MicroRNAs as Epigenetic Biomarkers of Pathogenetic Mechanisms of the Metabolic Syndrome Induced by Antiseizure Medications: Systematic Review. Journal of Clinical Medicine. 2025; 14(7):2432.
https://doi.org/10.3390/jcm14072432
Chicago/Turabian Style
Shnayder, Natalia A., Nikolai A. Pekarets, Natalia I. Pekarets, Diana V. Dmitrenko, Violetta V. Grechkina, Marina M. Petrova, Mustafa Al-Zamil, and Regina F. Nasyrova.
2025. "MicroRNAs as Epigenetic Biomarkers of Pathogenetic Mechanisms of the Metabolic Syndrome Induced by Antiseizure Medications: Systematic Review" Journal of Clinical Medicine 14, no. 7: 2432.
https://doi.org/10.3390/jcm14072432
APA Style
Shnayder, N. A., Pekarets, N. A., Pekarets, N. I., Dmitrenko, D. V., Grechkina, V. V., Petrova, M. M., Al-Zamil, M., & Nasyrova, R. F.
(2025). MicroRNAs as Epigenetic Biomarkers of Pathogenetic Mechanisms of the Metabolic Syndrome Induced by Antiseizure Medications: Systematic Review. Journal of Clinical Medicine, 14(7), 2432.
https://doi.org/10.3390/jcm14072432
